Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy
Latest Information Update: 06 Aug 2025
At a glance
- Drugs 64Cu SAR bisPSMA-Clarity Pharmaceuticals (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms Co-PSMA
Most Recent Events
- 17 Jul 2025 Status changed from recruiting to active, no longer recruiting.
- 08 Apr 2025 New trial record